CM
PTCT icon

Caption Management’s PTC Therapeutics PTCT Stock Holding History

Caption Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.6M Buy
302,100
+202,100
+202% +$14.3M 0.12% 179
2025
Q4 		$7.6M Buy
100,000
+40,000
+67% +$2.91M 0.05% 402
2025
Q3 		$3.68M Buy
60,000
+30,000
+100% +$1.56M 0.03% 599
2025
Q2 		$1.47M Buy
+30,000
New +$1.42M 0.02% 815
2024
Q3 		– Sell
-30,000
Closed -$917K – 1528
2024
Q2 		$917K Hold
30,000
– – 0.01% 684
2024
Q1 		$873K Sell
30,000
-130,200
-81% -$3.65M 0.01% 767
2023
Q4 		$4.42M Buy
160,200
+60,200
+60% +$1.38M 0.06% 377
2023
Q3 		$2.24M Sell
100,000
-38,200
-28% -$1.42M 0.03% 548
2023
Q2 		$5.62M Buy
+138,200
New +$6.76M 0.1% 247
2023
Q1 		– Sell
-168,400
Closed -$6.43M – 1458
2022
Q4 		$6.43M Buy
168,400
+138,400
+461% +$5.75M 0.1% 250
2022
Q3 		$1.51M Hold
30,000
– – 0.02% 732
2022
Q2 		$1.2M Buy
+30,000
New +$1.05M 0.02% 820
2022
Q1 		– Sell
-30,000
Closed -$1.2M – 1842
2021
Q4 		$1.2M Hold
30,000
– – 0.01% 976
2021
Q3 		$1.12M Sell
30,000
-60,000
-67% -$2.46M 0.01% 989
2021
Q2 		$3.81M Buy
+90,000
New +$3.86M 0.05% 450
2020
Q4 		– Sell
-30,000
Closed -$1.4M – 1200
2020
Q3 		$1.4M Buy
+30,000
New +$1.48M 0.03% 535
2020
Q1 		– Sell
-30,000
Closed -$1.44M – 1030
2019
Q4 		$1.44M Hold
30,000
– – 0.05% 426
2019
Q3 		$1.01M Sell
30,000
-38,000
-56% -$1.65M 0.05% 375
2019
Q2 		$3.06M Buy
68,000
+32,000
+89% +$1.26M 0.15% 185
2019
Q1 		$1.35M Sell
36,000
-14,000
-28% -$470K 0.07% 294
2018
Q4 		$1.72M Hold
50,000
– – 0.14% 201
2018
Q3 		$2.35M Buy
50,000
+32,500
+186% +$1.34M 0.13% 203
2018
Q2 		$591K Buy
+17,500
New +$546K 0.05% 302

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Caption Management's PTCT Position: Q3 2024 in Review

Caption Management sold out of PTC Therapeutics (PTCT) in Q3 2024, closing a stake of 6,300 shares — an estimated $193K sold.

Caption Management first reported a position in PTCT in Q2 2018 and held it in 11 quarters. The position peaked at $5.24M in Q4 2019. 202 funds tracked by Wall St. Rank hold PTCT as of Q3 2024.

  • Caption Management reported no remaining PTC Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 6,300 PTC Therapeutics shares in Q3 2024, an estimated $193K.
  • Caption Management first reported a position in PTC Therapeutics in Q2 2018 and held it in 11 quarters.
  • Caption Management's PTC Therapeutics position peaked at $5.24M in Q4 2019.
  • 202 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.